Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
57,285,340
-
Total 13F shares
-
46,516,239
-
Share change
-
+2,864,909
-
Total reported value
-
$947,641,508
-
Put/Call ratio
-
74%
-
Price per share
-
$20.37
-
Number of holders
-
210
-
Value change
-
+$64,706,175
-
Number of buys
-
116
-
Number of sells
-
92
Institutional Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (SUPN) as of Q2 2016
As of 30 Jun 2016,
SUPERNUS PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (SUPN) was held by
210 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
46,516,239 shares.
The largest 10 holders included
BlackRock Fund Advisors, Ranger Investment Management, L.P., VANGUARD GROUP INC, GLENMEDE TRUST CO NA, Bank of New York Mellon Corp, Invesco Ltd., ACADIAN ASSET MANAGEMENT LLC, Fiera Capital Corp, Neumeier Poma Investment Counsel LLC, and STATE STREET CORP.
This page lists
210
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.